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This study involved examining 5 years of existing medical records for patients 
previously in pulmonary rehabilitation, producing 333 subjects (180 female). The 
purpose of this study was to determine if any variables could significantly predict 
readmission, so a better pulmonary rehabilitation programs could be designed. Thus 
reducing the cost for the health care system as well as the patients themselves, and for 
in the patients future it would reduced illness, pain, and human suffering. A 
discriminant analysis was conducted in order to determine the likelihood of 
readmission into pulmonary rehabilitation using the independent variables of 6MWT 
difference, PEFR difference, BMI difference, LOS, start 6MWT, and end 6MWT. The 
discriminant indicated no clear gap discriminating between those readmitted and those 
never readmitted.  
However, out of the variables collected, although non-significant, the three 
strongest predictors were 6MWT start distance, 6MWT end distance, and BMI 
difference with statistical coefficients of 0.739, 0.688, and 0.586, respectively. It was 
also noted that a comparable healthy population was predicted to walk a great deal 
farther than the COPD patients involved in pulmonary rehabilitation, suggesting that 
the further the start and end 6MWT was below the normal values, the more likely it 
was that a patient would be readmitted into the pulmonary rehabilitation program. The 




pulmonary rehabilitation, the 6MWT starting distance was the strongest predictor, and 
the 6MWT as a whole was a better predictor than PEFR. However, it was clear that the 
predictors examined were not particularly strong predictors for readmission into a 
pulmonary rehabilitation program. The results provided showed that there was not one 
specific predictor that strongly indicated the likelihood for readmission, suggesting 
there are perhaps a plethora of variables outside of those linked specifically to 




C H AP T E R I  
IN T R O DU C T I O N 
 Most people would like to live a productive and normal life, but for some this 
can be difficult. For patients with Chronic Obstructive Pulmonary Disease (COPD) it 
can be a challenge just to walk from the house to the car, as “COPD is characterized by 
an airflow limitation that is not fully reversible” (Bratas, Espnes, Rannestad, & Walstad 
2010, p. 362). The estimated worldwide prevalence of COPD is 834 per 100,000, which 
constitutes approximately 44 million cases of COPD (Lundback et al., 2003). One 
common form of treatment for COPD is pulmonary rehabilitation. Both inpatient 
rehabilitation, where the patient checks “in” to the hospital, and outpatient 
rehabilitation, where the patient performs activities at home, have been shown to be 
highly effective in treating COPD (Ferrari et al., 2004; Hui & Hewitt, 2003; Ige, 
Olarewaju, Lasebikan, & Adeniyi, 2010; Jastrzebski, Gumola, Gawlk, & Kozielski, 
2006). Both inpatient and outpatient rehabilitation typically involve some form of 
supervised exercise training, education, emotional support, breathing exercises, 
psychosocial and group support, and may also include medical management (Ries, 
Kaplan, Limberg, & Prewitt, 1995). 
 When entering and exiting an inpatient pulmonary rehabilitation program, the 




level of functioning. In many cases, these assessments come in the form of a 6-minute 
walk test (6MWT) and measurement of one’s peak expiratory flow rate (PEFR). The 
objective of the 6MWT is to walk for as far as possible in six minutes, in order to 
assess the patient’s ability to ambulate. The objective of the PEFR is to measure how 
fast a person can exhale air, and is one of many tests that measure how well the lungs 
are working. These tests can also be used to assess the patient’s improvements as well 
as the program’s effectiveness for rehabilitating the individual (Balk & Elpern, 2002). 
 Inpatient pulmonary rehabilitation programs have been shown to improve a 
patient’s 6MWT distance, which is likely associated with an increase in the patient’s 
exercise capacity (Haave, Hyland, & Engvik, 2007). Furthermore, the improvement in 
exercise capacity may possibly be further affected by changes in the patient’s PEFR, 
which can be used to assess the patient’s airflow limitations (Quanje, Lebowitz, Gregg, 
Miller, & Pedersen, 1997). Exercise capacity as measured by 6MWT and PEFR scores 
also provide an indication of the likelihood of the patient being readmitted into a 
hospital setting for the same condition whether it be the emergency room or back into 
pulmonary rehabilitation. For example, when a patient has a low exercise capacity or 
PEFR following the completion of a pulmonary rehabilitation program, there is an 
increased likelihood of readmission following discharge, which is most likely caused 
by exacerbations (Hurst et al., 2010; Man, Polkey, Donaldson, Gray, & Moxham, 2004; 
Yohannes & Connolly, 2001). 
 An exacerbation is characterized by a sudden increase in uncontrolled 




and beyond normal day-to-day variations that is acute in onset and may warrant 
additional treatment in a patient with underlying COPD” (Burge & Wedzicha, 2003, p. 
46s). Exacerbations are a key cause for relapse in COPD patients (Gruffydd-Jones, 
Langley-Johnson, Dyer, Badlan, & Ward, 2007; Man et al., 2004) and it is important to 
identify factors that can indicate a higher likelihood of exacerbations in order to 
decrease the likelihood of such readmissions. Medical professionals are thus required to 
watch for declines in patient’s PEFR, which may be an indication of more frequent 
exacerbations (Donaldson, Seemungal, Bhowmik, & Wezicha, 2002). Such supervision 
is commonly seen throughout pulmonary rehabilitation and has been shown to prevent 
the declines in pulmonary function by identifying exacerbations factors, signs, and 
symptoms prior to the episode, thus reducing the frequency of exacerbations up to 24 
months post-discharge (Guell et al., 2000). 
 Exacerbations of COPD that lead to readmission into the emergency room or 
hospital admission are associated with an increased cost to both medical facilities and 
patients (Gruffydd-Jones et al., 2007). There is no agreed-upon clinical evidence that 
indicates the main causes for these exacerbations as there have been mixed results 
when attempting to reduce such readmission rates. Some pulmonary rehabilitation 
programs have been shown to reduce the risk of exacerbations that require follow-up 
hospital admittance; however the benefits from such programs tend to decrease with 
time, suggesting only a short-term reduction in hospital admittance rates. Despite this 





hospital admittance rates returning to the values commonly seen among those not 
participating in pulmonary rehabilitation in the first place (Seymour, 2010). 
 One type of program that has been found to be successful at limiting 
exacerbations is inpatient pulmonary rehabilitation, which is prescribed once the patient 
is discharged from the hospital by a physician (Gruffydd-Jones et al., 2007). 
Conversely, the lack of inpatient pulmonary rehabilitation for COPD patients is a factor 
associated with more frequent exacerbations (Burge & Wedzicha, 2003), often leading 
to more frequent relapses requiring a visit to the hospital. 
 While there is a substantial amount of research that shows the effectiveness of a 
pulmonary rehabilitation program on certain aspects of a patient’s life (Baltzan, Kamel, 
Alter, & Rotaple, 2004; Clini et al, 2001; Ferrari et al., 2004; Hui & Hewitt, 2003; Ige 
et al., 2010; Jastrzebski et al., 2006), there is no readily available data that indicates the 
likelihood of a patient being readmitted into a pulmonary rehabilitation program. It is 
plausible that health care professionals involved in inpatient pulmonary rehabilitation 
could compare the pre- and post-rehabilitation assessment tests of a patient in order to 
determine whether the patient needs longer involvement in the pulmonary rehabilitation 
program in order to minimize the likelihood of being readmitted post-discharge. 
 Multiple variables could be used to examine pre- and post-rehabilitation 
performance: PEFR, 6MWT, BMI, gender, age, and length of stay (LOS), among 
others. Collection of such performance data could be used to generate corollary data 
between patients’ pre- and post-rehabilitation differences and readmission into a 




relationship between assessment tests changes and readmission rates. Health 
professionals could thus refer to such correlations when a patient was considered for 
discharge from an inpatient pulmonary rehabilitation program. Therefore, the purpose 
of this study was to determine whether or not there was a difference between patients 
involved in pulmonary rehabilitation with regard to being readmitted into the program 
or not.  More specifically, we wanted to find the best predictor for readmission into an 
inpatient pulmonary rehabilitation program. Multiple research questions were asked: 
which variable was the best predictor for readmission into a pulmonary rehabilitation 
program, how well did each variable predict readmission, and which assessment test, 




C H AP T E R I I  
L I T E R A T UR E R E VI E W  
 Pulmonary rehabilitation is used for any COPD patient in a stable condition, but 
is disabled by respiratory symptoms (Ries et al., 2007). Those respiratory symptoms, 
such as exacerbations, can cause a COPD patient to be admitted to the hospital 
(Gruffydd-Jones et al., 2007 & Hui & Hewitt, 2003). Those exacerbations and hospital 
admissions can be reduced with the use of pulmonary rehabilitation (Bourbeau et al., 
2003), however, some patients that have participated in pulmonary rehabilitation may 
still be readmitted to the hospital and there may be a possibility of having to re-enter 
the pulmonary rehabilitation program (Sin & Tu, 2000). By avoiding an early discharge 
from the hospital or pulmonary rehabilitation the chance of re-admittance may be 
reduced. There may be help to determine a way for the health care professionals to see 
when a patient may be getting discharged to early from a pulmonary rehabilitation 
program.  
This literature review provided an evidence-based review of the literature 
pertaining to COPD itself, pulmonary rehabilitation programs, performance tests and 
norm-based tests used during pulmonary rehabilitation, and the readmission rates of 
pulmonary rehabilitation patients. The literature search was conducted by a 




of 1990 to 2012, with the exception of two papers to establish a history for PEFR from 
the years 1957 and 1959. The key words used were pulmonary rehabilitation and 
COPD, which were used in combination with the following words and phrases: 
inpatient, outpatient, 6-minute walk test, shuttle walk test, exercise capacity, peak 
expiratory flow rate, lung function test, exacerbation, length of stay, and readmission. 
The literature search was limited to articles published in peer-reviewed journals, in the 
English language, and the main criterion was the subjects having a pulmonary disease, 
mainly COPD. The search included randomized controlled trials, systematic reviews, 
observational studies, and epidemiological studies. 
Chronic Obstructive Pulmonary D isease 
 COPD does not have a single definition, but the multiple definitions all relate to 
a group of diseases that case airflow blockages, limitations, and breathing problems 
(Centers for Disease Control and Prevention, 2012), and the presence of these airflow 
limitations can increase the likelihood of developing lung cancer (Barnes & Celli, 
2009). COPD is a slow progressive disease that may go undetected for many years, and 
in many cases when the disease is diagnosed the patient could have lost up to 50% of 
their lung function (Lundback et al., 2003). The prevalence of an airway obstruction 
could be as high as 50% in those older than 70 years of age (Viegi, Pistelli, Sherrill, 
Maio, Baldacci, & Carrozzi, 2007). In 2005, COPD caused approximately 126,000 
deaths in the United States alone in people older than 25 years of age (Centers for 
Disease Control and Prevention, 2012), and COPD is projected to cause 4 to 5 million 




emphysema, chronic bronchitis, and asthmas (Centers for Disease Control and 
Prevention, 2012). 
 The main cause for COPD is cigarette smoking, however only 10-20% of heavy 
chronic smokers develop symptomatic COPD suggesting additional risk factors causing 
COPD (Teramoto, 2007). Some of the additional risk factors include air pollution, 
occupational exposure, and possibly genetic factors. More polluted areas have shown 
an increased prevalence of COPD diagnosis, symptoms, and respiratory hospitalization; 
thus allowing the association of COPD and air pollution to be clear and biologically 
plausible (Viegi et al., 2007). The risk of occupational exposure is approximately 15%, 
and can include occupations with exposure to grain, coal, welding fumes, and other 
mineral dusts (Anto, Vermeire, Vastbo, & Sunyer, 2001). The genetic factors have only 
recently begun to be studied, there are multiple genotypes being assessed on whether 
they are associated with COPD (Anto et al., 2001). However, genetic factors are not a 
singular cause for COPD, but are likely to influence the susceptibility to develop COPD 
(Viegi, 2007). 
Pulmonary Rehabilitation Program 
 Pulmonary rehabilitation dates back to the 1960s when Thomas L. Petty, a 
medical doctor, developed the first outpatient rehabilitation program (Casaburi, 2008). 
Prior to the outpatient rehabilitation program, patients with COPD were told to avoid 
activity that may cause dyspnea or the difficulty of breathing. Critics of Petty’s 
rehabilitation program questioned if benefits arose from the rehabilitation, but as the 




evidence which showed a reduction in the prevalence of dyspnea, increased exercise 
tolerance, and a greater quality of life regardless of the patient’s age (Baltzan et al., 
2004). 
 For inpatient and outpatient pulmonary rehabilitation programs there are three 
phases. Phase I occurs during hospitalization when nurses and dietitians meet with 
patients and their families to help them understand pulmonary disease and how to make 
the lifestyle adjustments needed to overcome it. Phase II, known as inpatient care, is 
done while living at home but periodically returning to a facility with medical 
professionals to perform the exercise training. Phase III, also known as outpatient care, 
is a home-based program where the patient lives and rehabilitates at home but goes to 
the medical facility for regular check-ups and appointments. Ferrari et al. (2004) 
examined the effectiveness of a minimally supervised outpatient rehabilitation program, 
which showed improvements in the quality of life and exercise tolerance of the patients 
involved. In comparison, Haave, Hyland, and Engvik (2007) studied the effectiveness 
of a 4-week inpatient rehabilitation program, which resulted in improvements in 
walking tolerance, lung function, perceived health status, and perceived quality of life 
for the participants, indicating that both types of programs can be effective. 
 The approach of pulmonary rehabilitation has changed from being a last resort 
for those with end-stage lung disease, to a near-essential component of COPD 
management (Balk & Elpern, 2002). The primary goal of medical professionals 
involved in pulmonary rehabilitation is to help the patient return to the highest level of 




to 6 months, depending on the patient’s specific problems and treatment goals. During 
phase II of the rehabilitation program, the majority of the time is spent performing an 
exercise-training program so the patient can be more independent in performing 
activities of daily living. The education component varies between each individual 
program but usually lasts from 1 to 3 hours per week (Van Stel, Colland, Heins, 
Rijssenbeek-Nouwens, & Everaerd, 2002) in order to give the patient more knowledge 
of the disease, hopefully reducing the need to rely on medical professionals. Some 
programs also provide behavioral evaluations by examining eating habits and coping 
mechanisms such as pursed lip breathing, which improves lung oxygenation and 
reduces dyspnea. These evaluations along with additional therapeutic support are used 
to promote the patient’s relaxation and coping mechanisms (Balk & Elpern, 2002). The 
combination of the above components creates a multidimensional program that can be 
more effective in the treatment of the disease than a one-dimensional program utilizing 
a single approach such as education or exercise alone. 
 The efficacy of pulmonary rehabilitation programs has been shown in multiple 
aspects of the patient’s physical and psychological wellbeing. Some research indicates 
patient improvement in dyspnea and functional capacity regardless of patient age, as 
indicated by enhanced walking and stair climbing (Baltzan et al., 2004). Improvements 
in walking distance and quality of life have also been seen in patients after 18 months, 
when rehabilitation programs were maintained (Troosters, Gosselink, & Decramer 
2000). Previous work also suggests that rehabilitation patients demonstrate 




fatigue, self-efficacy, and shortness of breath, despite little change in measure of 
pulmonary function, quality of life, depression, or the number of days the patient 
spends in the hospital (Ries et al., 1995). The differences in results suggest that not all 
patients respond in the same way, or to the same extent, to pulmonary rehabilitation 
programs (Haave et al., 2007). 
 Some problems with pulmonary rehabilitation may arise once the patient has 
finished the program and entered an outpatient program, which can either be 
community-based or home-based. Community-based or home-based programs have 
reported a wide range of adherence from as low as 25% (Cockram, Cecins, & Jenkins, 
2006) all the way up to 78% (Steele et al., 2008). For a COPD patient, the disruption of 
an already established lifestyle routine is a major barrier in attending pulmonary 
rehabilitation (Keating, Lee, & Holland, 2011). Since most health coverage will pay for 
a portion of the costs associated with hospital-based pulmonary rehabilitation, the 
inpatient program might be less expensive overall for the patient when compared to a 
home-based program where the patient’s health care assists very little with the financial 
burden (Clini et al., 2001). However, when health coverage is not available, the home-
based programs may be less expensive for the patient and are more convenient causing 
them to typically be easier to adhere to (Balk & Elpern, 2002). Therefore, it is prudent 
to consider that the affordability and availability of a program may affect the patient’s 
long-term adherence to the program. When a patient is able to afford the hospital-based 
program the patient may attend more days due to the enhanced accountability imposed 




have anyone present to motivate and ensure adherence to the program. However, the 
home-based program might not disrupt their daily routine, which may facilitate a 
greater adherence for some individuals. It is evident that both programs have their 
merits, and participation in either or both, must be based upon the individual needs and 
constraints of the patient. 
 Pulmonary rehabilitation is an effective treatment and can be made affordable 
for all patients with COPD, either through a hospital-based program or a home-based 
program (Balk & Elpern, 2002; Trooster et al., 2000; Griffiths, Phillips, Davies, Burr, 
& Campbell, 2001). Ideally, pulmonary rehabilitation should be multidimensional: 
involving both physiological and psychological therapy in order to achieve 
improvement in daily living functions, breathing comfort, and disease education for the 
patient. With the current information available indicating the effectiveness of 
pulmonary rehabilitation, it should be encouraged for all patients, with the 
understanding that each program should be tailored to the individual in order to reach 
their personal goals and regain their independence.  
Per formance T ests 
 The shuttle walking test (SWT) and the 6MWT are commonly used to measure 
exercise capacity for those individuals participating in pulmonary rehabilitation (Balk 
& Elpern, 2002). The SWT is performed by walking up and down a 10-meter path at a 
predetermined speed, which is dictated by an audio-signal from a tape, similar to that of 
a metronome, with the cadence of the audio-signal increasing every minute (Vagaggini 




to finish the shuttle in the allotted time given by the audio-signal. The 6MWT is 
performed by having the patient walk as far as they can in the allotted 6 minutes 
(Spencer et al., 2008). The patient is able to stop to rest and continue again when ready, 
and the test is stopped either when the patient experiences severe dyspnea, the 6 
minutes have elapsed, or self-termination which is when the patient requests to stop. 
 The SWT has been directly compared to the 6MWT through the examination of 
cardiorespiratory responses of 18 COPD patients after performing a walking test 
(Vagaggini et al., 2003). During a one-day session, patients performed two SWT and 
two 6MWT in a randomized order with a 30-minute break between each test. The 
patients’ heart rates, blood pressures, respiratory rates, oxygen saturations and dyspnea 
were measured before the test and within 60 seconds of test completion. A greater 
distance was covered in the second test when compared to the first, for both the 6MWT 
and the SWT. However, there were statistically significant differences only between the 
first and second tests distances for the SWT. Vagaggini et al. (2003) suggested that the 
significant change between the first and second test distances for the SWT might have 
been due to the fact that the SWT is more difficult to perform the first time due to a 
lack of familiarization, suggesting that the learning effect for the SWT may have been 
more pronounced than it was with the 6MWT. However, Vagaggini et al. (2003) did 
not consider the momentum needed to stop and accelerate for the SWT, which may 
have affected the patient’s distance achieved during each of the SWT. Despite these 
differences, the blood pressure, heart rate, respiratory rate, and oxygen saturation 




the 6MWT and SWT were equally effective measures of exercise capacity for COPD 
patients. However, other research has indicated higher maximum heart rates and the 
dyspnea reportings at the end of the SWT than at the end of the 6MWT (Singh, 
Morgan, Scott, Walters, & Hardman, 1992), suggesting that the 6MWT might be 
preferred for the medical safety of the patients with COPD. 
 Amongst the types of walk tests that measure exercise capacity in COPD 
patients, the 6MWT is the most commonly used, has a better tolerance level, is easier to 
administer, imitates activities of daily living more accurately, and has the greatest 
repeatability (Enright, 2003). The 6MWT is a self-paced test whereas other tests, such 
as the SWT, require patients to maintain a given pace. The primary component 
measured during a 6MWT is the total distance covered. Additional secondary 
measurements of fatigue, dyspnea, heart rate, and possibly oxygen saturation, are often 
also considered. Furthermore, the distance covered in a 6MWT has been shown to have 
a moderate relationship (r > .5) with one’s peak oxygen consumption, indicating that 
the 6MWT may be a valid measure of exercise capacity (Jenkins, 2007), refer to Table 
1 for more information on the reviewed literature. 
Despite the research advocating the use of the 6MWT, the findings of Spencer, 
Alison, and McKeough (2008) contradict the previous conclusions mentioned above. 
Spencer et al. (2008) conducted a study with 44 subjects performing multiple 6MWTs: 
two 6MWT prior to pulmonary rehabilitation, two immediately after 8-weeks of 
pulmonary rehabilitation, and two 3 months after the completion of an 8-week 




(2003), Spencer et al. (2008) found that the second test of the day always resulted in a 
greater distance being covered; the patients’ heart rate, oxygen saturation, and dyspnea 
responses also significantly improved the second time around. Such results indicate that 
familiarization and adequate warm-up can greatly influence the results of the 6MWT. 
Therefore, before performing a 6MWT there is a need for patients to be familiarized 
with the test, otherwise the results may be misrepresenting the improvements, as results 
tend to improve more after rehabilitation by those patients with a familiarization test 
than by those who were not familiar with the 6MWT (Jenkins & Cecins, 2010). 
Both the SWT and 6MWT are widely used tests to measure the exercise 
capacity of patients involved in pulmonary rehabilitation (Vagaggini et al., 2003; 
Rasekaba, Lee, Naughton, Williams, & Holland, 2009). However, the 6MWT appears 
to better reflect activities of daily living than do other walk tests, as it is self-paced. In 
addition, the 6MWT is a reliable, safe, and inexpensive test with good reproducibility 
for testing exercise capacity of the patients in pulmonary rehabilitation, specifically 
when the patients have been previously familiarized with the test. 
Norm-Based T ests 
 In order to estimate exercise capacity and lung function, the patient’s peak 
expiratory flow rate (PEFR) is often collected along with the 6MWT, and may be used 
to gauge patient improvements while participating in pulmonary rehabilitation (Balk & 
Elpern, 2002). PEFR is a measure of the fastest flow rate of exhaled air after maximal 
inspiration (Chaitra & Maitri, 2011). By collecting 6MWT and PEFR data, pre- and 




improvements following treatment. However, the 6MWT and PEFR do not necessarily 
reflect the same information, as the PEFR may not be an accurate measure of exercise 
capacity for those patients in pulmonary rehabilitation. For example, one recent study 
found that pulmonary rehabilitation resulted in improved exercise capacity; however, 
these changes in exercise capacity were shown to be independent of the pulmonary 
norm-based tests (PEFR), which did not improve following pulmonary rehabilitation 
(Ige et al., 2010). Similar results were reported by Ries et al. (1995) who found no 
increase in lung function tests; these results suggest that although norm-based tests are 
beneficial, the data obtained from them may not be a valid estimate of functional 
exercise capacity. Nevertheless, pulmonary function tests are used as an outcome 
measure to assess disease severity, prognosis of the patient, and as a measure of 
mortality (Wilson, MacDonald, Watter, & O’Rourke, 2006).  
To compare the different means of measuring ventilatory capacity, Wright and 
McKerrow (1959) compared the PEFR and the forced expiratory volume in 1 second 
(FEV1) against each other. PEFR came into consideration as an alternative to forced 
expiratory volume (FEV) because FEV1 previously required a connection to an electric 
supply, whereas PEFR did not. The adoption of the PEFR made performing ventilatory 
tests simpler by introducing an instrument called a flowmeter. Higgins’ (1957) studied 
men aged 55 to 64 and found a high correlation (r =  .86) between PEFR and FEV in 
0.75 seconds. The difference being that FEV is a measure of the total volume forcefully 
expired after one breath, whereas FEV1 or FEV.75 are measures of forcefully expired air 



















Troosters, 2000 Randomized 
Controlled Trial  
 
50 COPD Patients FEV1 & 6MWT 6 months 6MWT inc. 52m, FEV1 inc. .19L/min 
Haave, 2007 Interventional Clinical 
Study 
 
92 COPD Patients 6MWT & FEV1 4 weeks 6MWD inc. an average of 25m and were 
significantly correlated with FEV1,  
 
Baltzman, 2004 Epidemiological Study 230 COPD Patients 6MWT April 1999 – March 
2000 
6MWT inc.significantly for 40% of the 
patients 
 
Spencer, 2008 Prospective, 
Longitudinal Study 
 
40 COPD Patients 6MWT & Lung 
Function 
3 months/PR 8 
weeks 
Inc. of 27m for 6MWT from walk 1 to 
walk 2 
Man, 2004 Randomized 
Controlled Trial 
 
42 COPD Patients SWT 8 weeks SWT distance inc. 60m 
Donaldson, 2002 Observational Study 109 COPD Patients FEV1 & PEFR November 1995-
November 1998 
 
The more frequent the exacerbations the 
greater the decline in FEV1 and PEFR 
 
Guell, 2011 Randomized 
Controlled Trial 
 
60 COPD Patients 6MWT & FEV1 2 years/ 3 month PR Inc. in 6MWT (p=0.0001), reduced 
exacerbations (p<0.0001) 
Ige, 2010 Randomized 
Controlled Trial 
44 COPD Patients SWT, PEFR, & FEV1 
 
6 weeks SWT inc. 25m 
  Note: Inc.= Increased  
17 
18 
 The high correlation between PEFR and FEV suggests that the two can be used 
in a similar manner to assess pulmonary function (Higgins, 1957; Wright & Mckerrow, 
1959). More recent research has compared the frequencies of exacerbations over the 
course of a year in patients with COPD regarding their decline in lung function, as 
measured by both PEFR and FEV1 (Donaldson et al., 2002). The patients were 
measured every 3 months over the course of a year, and those patients experiencing 
more frequent exacerbations showed a significantly greater decline in PEFR and FEV1, 
throughout the year, than those with infrequent exacerbations. Similarly, Troosters et 
al. (2000) found that patients who died during their study, which assessed the short- and 
long-term effects of outpatient rehabilitation in COPD patients, had a significantly 
lower FEV1 than those who survived. With declines in both PEFR and FEV1 coinciding 
with an increased frequency of exacerbations, previous research confirms Wright and 
Mckerrow’s analysis that PEFR and FEV1 can be viewed as ventilatory tests that 
provide similar information (Donaldson et al., 2002; Troosters et al., 2000), as 
indicated by the high correlation between the two (r =  .84) (Emerman & Cydulka, 
1996; Gautrin, D’Aquino, Gagnon, Malo, & Cartier, 1994). 
 When comparing baseline values taken prior to pulmonary rehabilitation with 
post-rehabilitation values over 72 months, Ries et al. (1995) found that pulmonary 
rehabilitation produced significant changes in endurance exercise testing using an 
incremental, symptom-limited VO2 test on a treadmill, but no change in pulmonary 
function (FEV1). Ige, Olarewaju, Lasebikan, and Adeniyi (2010) reported similar 
findings and concluded that the improvements made during the SWT were independent 
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of the changes in the FEV1 ventilatory function test. Ige et al. (2010) enrolled patients 
with COPD in a 6-week outpatient program, in which they attended twice a week. 
Exercise capacity and pulmonary function of the patients were assessed prior to and at 
the completion of the program. The initial measurements included questionnaires, 
ventilatory tests, and oxygen saturation tests before and after a SWT, as well as a 
resting ECG. The results at the end of the 6-week program showed no significant 
change in FEV1, vital capacity, PEFR, baseline oxygen saturation, or in breathlessness 
measured on the Borg scale (Appendix A). However, the SWT distances were 
increased by a mean of 25 meters, indicating that performance in functional exercise 
tests such as the SWT may be independent of pulmonary function tests. 
 A study by Ferrari et al. (2004) produced inconsistent results when examining the 
effects of outpatient rehabilitation (education, upper and lower limb exercise, and 
stretching for 12 weeks) on pulmonary function, exercise tolerance, and quality of life 
in patients with COPD. In order to monitor these variables, patients were assessed 
before and after rehabilitation using a variety of pulmonary functions tests (FVC, FEV1, 
FEV1/FVC ratio, functional residual capacity, total lung capacity, and residual 
volume/total lung capacity ratio), graded exercise test, and a Health Status Index (SF-
36), which yields 8 separate subscales: physical function, physical role, bodily pain, 
general health, vitality, social function, emotional role, and mental health. The 
rehabilitation program did not produce any significant variations or improvements in 
the pulmonary tests including the FEV1, even though the exercise tolerance was 
significantly increased. With the Health Status Index (SF-36), the patients began with 
low scores when compared to those of healthy adults, but after rehabilitation, the  
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patients showed significant improvement on six of the 8 subscales (Appendix B). 
Considering the fact that the FEV1 showed little variation between pre- and post-
rehabilitation testing, one might assume that PEFR would also remain unchanged as 
PEFR and FEV have such a high correlation (r = .83), as shown by Gautrin et al. 
(1994); these findings provide further support for the proposed independence of 
pulmonary testing and exercise capacity. 
 The PEFR has been shown to be reliable measurement of lung function (Douma 
et al., 1997). However, the PEFR did not always show the same improvements as 
exercise capacity tests did, suggesting that the results of the PEFR and the 6MWT may 
be independent of one other. Considering this independence, and the fact that PEFR did 
not increase as a patient progresses, suggests that PEFR may not be the most reliable 
predictor of readmission rates for those participating in pulmonary rehabilitation. 
Conversely, the 6MWT appeared to be more sensitive to changes in patient’s functional 
capabilities and therefore may more accurately foreshadow future readmission rates. 
Readmission Rates 
  COPD patients account for 1.4 million days spent in the hospital per year; this 
time is primarily attributed to elderly patients, as they have a higher frequency of 
disease and relapse compared to their younger counterparts (Sin, & Tu, 2004). Of the 
emergency room visits from COPD patients between December 2005 and March 2006, 
28% were caused by exacerbations from the disease; however some other 
psychological, social, and medical factors such as poor quality of life, environmental 
pollutants, and bacterial respiratory infections were also responsible for readmission 
(Gruffydd-Jones et al., 2007). With the high frequency of readmissions in COPD 
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patients, researchers have begun to study the effectiveness of pulmonary rehabilitation 
on the patients’ readmission rates (Man et al., 2004). However, many studies examining 
readmission have only looked at patients with COPD after they have been readmitted to 
the emergency room, rather than examining the re-enrollment into a pulmonary 
rehabilitation program. Another inconsistency throughout the re-admittance research is 
the length of time that data are being collected, which ranges anywhere from 15 days 
(Sin & Tu, 2004) to 1 year (Troosters, Casaburi, Gosselink, & Decramer, 2005). The 
above discrepancies suggested that the data may not be consistent across studies due to 
such a wide range in period assessment, which was known to affect the long-term 
effects of a pulmonary rehabilitation program, and the effects were often still seen after 
12 months completion (Guell et al., 2000), refer to Table 2 for more literature reviewed 
for hospitalizations and pulmonary rehabilitation assessment tests. 
 Patients are usually able to safely participate in pulmonary rehabilitation shortly 
after experiencing an exacerbation, and when doing so, patients participating in such 
programs have been shown to have an expedited recovery (Man et al., 2004). Some 
studies have looked at the effectiveness of pulmonary rehabilitation on patient relapse 
rate; those studies that have focused on post-pulmonary rehabilitation and hospital 
admissions have shown fewer hospitalizations and shorter stays when compared to a 
control group not participating in a pulmonary rehabilitation program (Troosters, 2005; 
Hermiz et al., 2002; Hui & Hewitt, 2003). Man (2004) found that a treated group was 
readmitted 30% less frequently and had fewer inpatient days, when compared to a 
control group not participating in pulmonary rehabilitation. Along with fewer 
hospitalizations, intervention groups have also been shown to have shorter stays. Hui 
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and Hewitt (2003) showed a reduction in the length of stay from a mean of 7.4 days to 
3.3 days following the completion of a pulmonary rehabilitation program; this shorter 
stay was concomitant to a reduction in hospital admission from 1.2 admissions per 
patient per year to 0.6 admissions. Even without a reduction in hospital readmissions, 
the practice of pulmonary rehabilitation appears to be a more effective use of the 
money and time of the health care system as it facilitates more consultations on the 
general practitioners’ premises rather than alternative costly at-home visits (Griffiths et 
al., 2000). 
 Hui and Hewitt (2003) collected data from patients involved in 18 months of 
pulmonary rehabilitation. The authors found that up to 12 months after the completion 
of the program both the number of patient hospitalizations and the length of the stay 
were reduced; they also noted significant increases in the 6MWT with a mean increase 
of 90.5 meters. Despite these gains, there were no significant changes in the FEV1 lung 
functions. Griffith et al. (2000) indicated similar findings, reporting no significant 
differences in the lung function tests but significant changes in the exercise capacity 
tests, and a reduced number of hospital days for those individuals participating in 
rehabilitation for a duration of 6-weeks. Such lung function tests, along with 
measurements of walking capacity were collected before, immediately following the 6-
weeks, and 1 year after either usual treatment (primary-care follow-ups with no 
pulmonary rehabilitation) or rehabilitation. Griffiths et al. (2000) found that there were 
no significant differences between the control and the rehabilitation group for the lung 
function values, but there were significant improvements in the rehabilitation group for 
the SWT at 6-weeks, the benefits of which appeared to still be present even after a year. 
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These findings coincide with the substantially lower number of days spent in the 
hospital by the rehabilitation group when compared to the control group, likely due to 
the increased functional capacity of those individuals participating in pulmonary 
rehabilitation. The improvements in exercise capacity tests and hospital days suggest 
that the exercise capacity test may have a stronger relationship with relapse rates than 
do lung function test. 
 There was contradictory research regarding the relationship between lung 
function tests, exercise capacity tests, and corresponding relapse rates. Bourbeau et al. 
(2003) found no differences between the usual care group, regular check-ups only, and 
the pulmonary education group in either the lung function tests or the 6MWT, but the 
acute exacerbations were less frequent in the intervention group, resulting in reduced 
hospital admission. The similarities in the lung function and 6MWT could have been 
due to the intervention group only receiving education rather than a multidimensional 
program including exercise. Even when receiving pulmonary rehabilitation, there are 
still other related risk factors which often result in hospital admission, such as bacterial 
respiratory infections, age, and co-morbid diseases, such as streptococcus pneumonia, 
which is a type of bacterial infection, or pulmonary hypertension, which is common in 
COPD patients (Yohannes & Connolly, 2001). 
 
 
Table 2  
 
Literature Reviewed for Hospitalizations and Pulmonary Assessment Tests 
Author Type of Study Particpants Assessment Duration Results (significant) 
Cockram, 2006 Randomized 




& Hospital Utilization 
8 weeks 6MWT mean inc. 19.1m & reduced 
hospital usage 




FEV1, Walking Test, 
& Hospital Utilization 
8 weeks Inc. in walking tests, slight not 
significant decease in duration of 
stay 




Hospital Utilization June 2005- 
April 2008 
The hospital admission for COPD 
exacerbation was lowered 







& ER Visits 
February 1998- 
July 1999 
Hospital usage for exacerbation 
reduced 39.8%, other health 
problems reduced 57.1%, & ER 
reduced 58.9% 




Hospital Utilization 1 year study/6 
week PR 
PR group had less days spent in the 
hospital than control group (mean 





6MWT, FEV1, & 
Hospital Utilization 
18 months 6MWT inc. 90.5m, hospital 
admission for exacerbations went 
from 1.2 to .6 per year, & LOS went 
from 7.4 days to 3.3 days per year 




Hospital Utilization 8 weeks PR group was readmitted 30% less 






 There is no way to fully prevent relapses and readmissions in patients with 
COPD. However, there may be a way to promote adherence to the pulmonary 
rehabilitation program, thereby reducing the number of readmissions suffered by 
patients. The 6MWT seemed to be a more accurate measure of readmission probability 
when compared to the PEFR. Nevertheless, using both the 6MWT and PEFR together 
may provide a more accurate assessment of pulmonary and functional capabilities, and 
therefore provide a more precise estimate of the likelihood of hospital readmission. 
These comparisons may in turn be an effective tool used by health care professionals in 
order to determine the appropriateness of patient discharge and the corresponding risk 
for readmission. 
Summary 
 Pulmonary rehabilitation is intended to restore the patient to the highest level of 
independent functioning (Ries et al., 2007). Inpatient and outpatient pulmonary 
rehabilitation have been shown to be effective tools in the treatment of COPD, 
especially if they are multidimensional programs (Balk & Elpern, 2002; Trooster et al., 
2000; Griffiths, Phillips, Davies, Burr, & Campbell, 2001); and has been shown to 
reduce the number of hospitalizations along with reducing the length of the stay (Man, 
2004). Pulmonary rehabilitation uses assessment tests to determine the effectiveness of 
the program; among these tests are 6MWT and PEFR. The 6MWT is the most 
commonly used because it is easy to administer and imitates activities of daily living 
more accurately (Enright, 2003). While the PEFR has been shown to be a reliable 




not always increase with the patient’s progress (Gautrin et al, 2004). This finding 
suggested that the 6MWT may be more accurate at predicting readmission rates over 
the PEFR. The readmission rates of COPD patients has been researched and analyzed 
for hospital admissions, but there was a lack of research for the re-entry into a 
pulmonary rehabilitation program. The need for further research on the premature 
discharge of patients from pulmonary rehabilitation and identifying the predictors of 
the readmission of patients re-entering pulmonary rehabilitation, which may be 





C H AP T E R I I I  
M E T H O D 
Study Design 
 The design of this study was a case-control study. This study involved searching 
through 5 years of existing medical records for patients who had previously participated 
in Altru Health System’s pulmonary rehabilitation programs (Grand Forks, ND). The 
intent of this study was to examine the difference between a group of readmitted (R) 
patients (cases) and a group of never readmitted (NR) patients (controls) from a 
pulmonary rehabilitation program, along with the relationship between the dependent 
variable of pulmonary rehabilitation readmission and multiple independent variables 
including 6MWT and PEFR differences, BMI difference, LOS, and start and end 
6MWT. These comparisons were used to find the best predictor of readmission into a 
pulmonary rehabilitation program. 
Participants 
 The participants included in this study were both male and female patients of 
the pulmonary rehabilitation unit during the 5-year period of 2007 – 2011. Patients that 
did not complete the pulmonary rehabilitation sessions were not included in the 
analysis. Thirty-one patients were excluded from this study due to incompletion of the 





were pre-existing and the data to be collected contain no identifiable markers. 
However, a waiver of authorization was granted through both the Altru Health System 
and University of North Dakota (UND) Institutional Review Board (IRB). The waiver 
of authorization was obtained to forgo the authorization requirement from the 
participant as disclosure of protected health information (PHI) involved provides 
minimal risk to the participant’s privacy; the research could not be practically done 
without this waiver due to restricted access and use of the PHI. Altru IRB approval was 
granted on May 24, 2012 with an IRB number of ST-107, and UND IRB approval was 
granted on May 21, 2012 with an IRB number of 201205-401.  
Procedures 
 The data was collected in the fall of 2012 using computer access to medical 
records of patients that were previously involved in pulmonary rehabilitation at Altru 
Health System from a previous 5 year period, 2007-2011. Altru had a full list of all 
patients with COPD from 2007-2011 using code GO424. Each individual patient 
number (MRN) was entered in the EDM database for years 2007-2010, and into the 
Epic database for the year 2011. The patients that were involved in pulmonary 
rehabilitation were included in the study. The inclusion criteria was that the patient had 
to start pulmonary rehabilitation at Altru Health System between 2007-2011 and 
complete the same program also at Altru prior to 2011, a patient was omitted if they did 
not complete the program at Altru or if the patient had died prior to completion. The 
information obtained from the medical records was the patient’s age, pre- and post- 




patient was readmitted into the pulmonary rehabilitation program at a later date once or 
multiple times, and LOS during pulmonary rehabilitation. When necessary, the 
difference was found between the pre- and post- rehabilitation measurements. Table 3 
is an example of the spreadsheet on which the data was recorded. 
Statistics 
 A discriminant analysis was conducted in an attempt to discriminate between 
groups (R vs. NR) based upon if group membership (R VS. NR) be significantly 
determined by the predictor variables examined by the prediction strength of each of 
the independent variables.  Within the discriminant analysis, the statistical procedures 
used were the Eigenvalues, Wilks’ lambda, canonical discriminant functions, structure 
matrix, and classification results.  These functions were conducted in order to find 
grouping percentages of the patients. The 6MWTdifference, PEFR difference, 6MWT 
start distance, 6MWT end distance, LOS and BMI difference were used as predicting 
variables for patient readmission into pulmonary rehabilitation. Statistical Package for 
the Social Sciences, IBM Statistics Version 19 was used to perform the analysis and 





Recording Data Spreadsheet 
ID Age Sex LOS Height Weight Pre-PEFR Post-PEFR Pre-6MWT Post-6MWT Re-admit 
1 72 Y M 239 D 1.80 m 95.30 kg 5.84 L/s 7.14 L/s 1100 ft. 2006 ft. No 
2 64 Y M   98 D 1.74 m 122.52 kg 3.73 L/s 4.44 L/s 686 ft. 1056 ft. Yes 
3 88 Y M 153 D 1.66 m 68.90 kg 8.05 L/s 8.01 L/s 571 ft. 1636 ft. Yes 
4 72 Y F 212 D 1.60 m 91.58 kg 3.15 L/s 3.69 L/s 650 ft. 360 ft. Yes 
 Note: Y= years, M= male, F= female, LOS = Length of Stay, D= days, m = meters, kg = kilograms, L/s= liters per second, ft.= feet 




C H AP T E R I V 
R ESU L TS 
 A discriminant analysis was conducted to predict whether a patient would be 
readmitted into a pulmonary rehabilitation program or not. Subject demographics 
indicated a sample consisting of 98% Caucasians, with a mean height of 1.67 m, a 
mean weight of 84.79 kg, and a mean age of 69 years. The height, weight, and age was 
collected for a total of 333 subjects (180 female); BMI was calculated using the height 
and weight, and can be found in Table 4. 
Table 4 
Participants Base Data 
                             Males Females 
Variable Mean Std. Deviation Mean Std. Deviation 
Age (years) 70.71   8.93 67.01 10.74 
Height (m)   1.74   0.07   1.60   0.06 
Weight (kg) 90.80 21.22 78.78 20.18 
BMI (kg/m2) 29.79   8.93 30.74 10.74 
  
 The independent variables used as predictors were as follows:  LOS, PEFR 
difference, BMI difference, 6MWT start distance, 6MWT end distance, and 6MWT 
difference. There were important, yet non-significant, mean differences between the 
NR group and the R group in the predictors of the start 6MWT and the end 6MWT, as 






 Never Readmitted Readmitted 
Variable Mean Std. Deviation Mean Std. Deviation 
LOS (days) 154.76 67.91 155.64 76.88  
6MWT Start (ft.) 769.77 355.42 672.47 326.16  
6MWT End (ft.) 995.53 397.54 898.32 292.92 
6MWT Diff. (ft.) 225.75 376.10 225.85 318.37 
PEFR Diff. (L/s) 0.18 1.01 0.11 0.76 
BMI Diff. 
(kg/m2) 0.16 1.91 -0.26 1.70 
 
 The discriminant function also showed a non-significant association between 
the predictors and the groups as the predictors accounted for only 3% of group 






















Lambda Chi-square df Sig. 





 However, despite the lack of significant differences between groups, the 
structure matrix indicated that 6MWT start distance was the strongest predictor (.739), 
whereas 6MWT end distance was the next strongest (.688), and BMI difference was the 




Finally, the cross-validation grouping showed that 74.2% of the cases were 
classified correctly, as shown in Table 9. The grouping of the patients was determined 
to be 248 NR patients and 85 R patients, suggesting that 74% of the patients had never 
been readmitted whereas 26% had.  The answers for the three questions to be answered 
by this study were determined as well. The primary question of which variable was the 
best predictor for readmission into a pulmonary rehabilitation program determined that 
the 6MWT was the strongest predictor. The secondary question of how well did each 
variable predict, concluded that that the predictors examined were not particularly good 
at predicting readmission into a pulmonary rehabilitation program. The final question  
 
Structure M atr ix 
  Function 
1 
6MWT_start   .739 
End_MWT   .688 
BMI_diff   .586 






was which assessment test, 6MWT or PEFR, was better at predicting readmission, and 
it was deduced that the start and end 6MWT was the better predictor for readmission. 
Table 9 
Classification Results 
Classif ication Results 




Total       Never 
               
Readmit 
Original Count Never   248 0               248 
Readmit    84 1                 85 
% Never 100.0  .0 100.0 
Readmit 98.8 1.2 100.0 
Cross-
validateda 
Count Never 247          1               248 
Readmit   85 0                 85 
% Never 99.6 .4 100.0 





C H AP T E R V 
D ISC USSI O N 
 Pulmonary rehabilitation has been around since the 1960s and has been shown 
to be an effective tool in managing COPD, and patients who have participated in such 
programs have been shown to have an expedited recovery (Man et al., 2004). Typically, 
when patients entered and exited the inpatient pulmonary rehabilitation program, they 
were required to perform initial assessment tests in order to determine their level of 
functioning. In this particular study, these initial assessments came in the form of 
6MWT and PEFR. The purpose of this study was to determine whether or not there was 
a difference between those patients being readmitted into pulmonary rehabilitation and 
those patients who were not readmitted.  In addition to the overall purpose, this study 
examined specific variables that might aid in predicting whether a patient would be 
readmitted into a pulmonary rehabilitation program or not. The three questions to be 
answered were: which variable was the best predictor for readmission into a pulmonary 
rehabilitation program, how well did each variable predict, and which assessment test, 
6MWT or PEFR, was better at predicting reentry?  Thus we examined the dependent 
variable of reentrance to pulmonary rehabilitation as it was influenced by the 
independent variables of 6MWT difference, PEFR difference, start 6MWT, end 
6MWT, BMI difference, and LOS. The discriminate analysis showed important, 




the predictors of the start 6MWT and the end 6MWT, but a non-significant association 
between all the predictors and the NR and R groups. 
 The main finding of this study was that even though it was not significant, the 
strongest predictor for readmission was the start 6MWT. The end 6MWT and BMI 
difference were the second and third strongest predictors respectively, although also 
non-significant. The second question, which was how well did each variable predict, 
was answered by the fact that none of the predictors were significantly different 
between groups, indicating that no predictor was particularly strong at predicting 
readmission. Finding no significant predictors suggests there are many factors that 
influence the readmission to pulmonary rehabilitation, and that perhaps many of these 
fall outside the scope of what are considered traditional characteristics of pulmonary 
inadequacy.  
 However, a non-significant but possibly important finding was the difference 
between the start and end 6MWT between the NR and the R groups.  The mean 6MWT 
taken at the start and end of pulmonary rehabilitation for the NR group was 770 ft. (235 
m) and 996 ft. (304 m), respectively. While the mean 6MWT taken at the start and end 
of pulmonary rehabilitation for the R group was 672 ft. (205 m) and 898 ft. (274 m), 
respectively. The differences between the start 6MWT and the end 6MWT for both 
groups were increased approximately 226 ft. (69 m). According to Redelmeier et al. 
(1997) and Puhan et al. (2008), an increase of 226 ft. (69 m) for the 6MWT is an 
important change when considering the patient’s self-perception of their overall health; 




the idea that they are approaching the performance level of a healthy population. 
Furthermore, Redelmeier et al. (1997) reported that 54 m was seen as the point in 
which patients interpreted their performances to be changed in a practically significant 
manner. Another study by Puhan et al. (2008) found that the 6MWT should change by 
approximately 35 m for patients with moderate to severe COPD in order to represent a 
minimally important difference as interpreted by the patient in order to be aware of the 
efficacy of pulmonary rehabilitation on their health. With the patients of the current 
study showing an increase of 226 ft. (69 m) for each group, the changes in the 6MWT 
were viewed as important for the patient’s perception of their overall health and their 
view on the efficacy of the pulmonary rehabilitation program. 
 Other researchers have found increases in the 6MWT as well, such as Spencer, 
Alison, and McKeough (2008), who had 44 subjects perform multiple 6MWT: two 
prior to pulmonary rehabilitation, two immediately after 8-weeks of pulmonary 
rehabilitation, and two 3 months after the completion of pulmonary rehab. The authors 
found a significant improvement in 6MWT performance when comparing pre- and 
post- pulmonary rehabilitation values with those taken 3 months later. The results of 
this study were similar for the pre- and post- 6MWT to the findings of Spencer et al 
(2008), although this study has non-significant results.  The 6MWT start and end 
distances for each group of this study indicated a difference of 97 ft. (30 m) from pre- 
to post-rehabilitation, with a greater distance being covered by the NR group in 
comparison to the R group. When the two groups were compared, the change in 6MWT 




between the NR and R groups. Although, the 6MWT difference was not the best 
predictor compared to the PEFR difference, the start and end 6MWTs were greater in 
the NR group, suggesting that the start and end 6MWTs were better predictors than the 
PEFR difference itself, however none of the “predictors” were significant. This finding 
answered the third question, which assessment test, 6MWT or PEFR, was better than 
the other, by indicating that the 6MWT was a better predictor than PEFR.  
 The 6MWT start and end distances were compared to predicted normal values 
for the same healthy demographic of a similar age, height, and BMI, which was 
determined using equations taken from Jenkins et al. (2009; appendix C). A comparison 
to the predicted norms for both the start and end 6MWT distances for male and female 
subjects was examined. The male subjects had a start 6MWT and end 6MWT distance 
of 745 ft. (227 m) and 971 ft. (296 m) respectively, whereas the normal value for 
healthy comparable males is 2108 ft. (643 m). The differences between the current 
male subjects and the healthy comparable males for the start 6MWT and end 6MWT 
distances were found to be 1363 ft. (416 m) and 1137 ft. (347 m), respectively. The 
female subjects showed similar deficiencies, walking 716 ft. (218 m) for the start 
6MWT and 927 ft. (282 m), for the end 6MWT whereas the normal value for healthy 
comparable females was 1885 ft. (574 m). The differences between the female subjects 
from this study and the healthy comparable females were 1169 ft. (356 m) and 958 ft. 
(292 m) for the start and end 6MWT distances, respectively. It is therefore clear that a 
comparable healthy population was predicted to walk a great deal farther than the 




considering the lack of pulmonary constraints for a healthy demographic. The 6MWT 
should still be considered a good measure of pulmonary rehabilitation since it is able to 
have a predicted normal value to compare with and is able to view the differences made 
pre- and post-pulmonary rehabilitation. With similar 6MWT differences between 
groups and a greater start 6MWT distance for the NR group, it may be suggested that 
the further the patient’s start 6MWT is from the norm (i.e., the shorter their walking 
distance), the more likely to be readmitted later, but currently there is inadequate 
evidence to confirm this. 
 Past studies have observed similar results to those found in this study, with 
increases in the 6MWT while the PEFR remains unchanged. Hui and Hewitt (2003) 
found that after an 8-week pulmonary rehabilitation program there were no significant 
changes in patient lung functions; however the 6MWT distances were increased by 90 
m. Ige et al. (2010) also found that after a 6-week pulmonary rehabilitation program 
walking tests were improved by 33 m yet no improvements were found in the patient’s 
ventilatory tests. Ferrari et al. (2004) used a rehabilitation program to examine the 
effects on exercise tolerance and quality of life in patients with COPD. The 
rehabilitation included an education program, upper and lower limb exercise, and 
stretching for a 12-week program. The rehabilitation showed that there were no 
significant variations in the pulmonary tests when comparing pre- and post-values, even 
though the exercise tolerance was increased. Finally, Ries et al. (1995) compared pre- 
and post-rehabilitation values over 72 months and found that pulmonary rehabilitation 




significant change in pulmonary function. The above studies support the notion that 
PEFR does not always reflect changes in patient performance or provide the same 
information as the exercise capacity tests do. Furthermore these studies suggest that the 
results of the PEFR and the 6MWT may be somewhat independent of one another, 
which is in agreement with the findings of the current study. Our results, while non-
significant, suggested that there was a small difference between the NR and the R 
groups with the PEFR difference, but none for the 6MWT difference. However, there 
was an important difference in 6MWT distance covered at the start of the program 
when compared to that at the end (30 m), whereas there was no difference in starting 
and ending PEFR values. These findings may suggest that the start or end 6MWT 
scores alone more effectively discriminate between readmission groups than do the 
differences for 6MWT and/or PEFR. 
 While a significant improvement in lung function following pulmonary 
rehabilitation is uncommon, a few studies have indicated an improvement in both lung 
function tests (e.g., PEFR, FEV1) and 6MWT. Haave, Hyland, and Engvik (2007) had 
92 patients enrolled in a 4-week pulmonary rehabilitation program and found 
significant improvements on the walking test and lung function test. However, the 
authors concluded that the improvements on the walking test were independent of the 
changes in lung function. Similarly, Riario-Sforza et al. (2005) compared between two 
groups involved in a 4-week pulmonary rehabilitation program, with one group 
consisting of 37 patients with exacerbations and the other group consisting of 37 




significant improvements in the 6MWT with an increase of at least 54 m and significant 
improvements in the lung function test. However, the authors found that the patients 
experiencing exacerbations had no significant difference for the 6MWT and less 
significant lung function tests than the no exacerbation group. Contrary to the above 
findings, there was little consistent data that proved that pulmonary rehabilitation was 
able to significantly improve lung function, and that the progressive decline in lung 
function in COPD patients cannot be prevented by treatment (Riario-Sforza et al., 
2005). However, pulmonary rehabilitation may provide a valuable role in slowing the 
decline of lung function and limiting the effects seen, despite not fully preventing or 
reversing the loss of lung function. 
 Other factors such as drug treatments may be the underlying cause of the 
improvement in respiratory performance instead of pulmonary rehabilitation alone. 
Therefore, when considering these respiratory performance changes following 
pulmonary rehabilitation, it is difficult to determine the exact mechanism underlying 
such adaptation (Riario-Sforza et al., 2005). If drug treatments are responsible for 
driving the change in pulmonary function, perhaps they should be accounted for and 
taken into consideration for future assessment of pulmonary rehabilitation. However, 
the pulmonary function tests could be used to determine the effectiveness of a 
particular drug intervention on pulmonary performance. Finally, Wehrmeister et al. 
(2011) had a review of the literature on COPD patient rehabilitation, and 12 analyses 
were obtained that included pre- and post-rehabilitation pulmonary function. Out of 




of those 6 analyses was due to an increase in pulmonary function from pre- to post-
rehabilitation. These studies suggest that 6MWT often increase despite little change in 
PEFR. Although, the possibility of simultaneous adaptation in 6MWT and PEFR exists, 
it was not observed in the current study. Furthermore, researchers must take caution 
when interpreting the data of medicated patients, as their current level of drug treatment 
may influence the likelihood of one or both variables showing improvement. 
 The BMI difference between the start and end of pulmonary rehab was the third 
best predictor found in this study, although it was not significant.  However, the 
changes were small: a 0.15 kg/m2 increase for the NR group and a 0.26 kg/m2 decrease 
for the R group. These results were consistent with those from other studies. For 
example Sava et al. (2010), found that the changes in BMI after rehabilitation were 
small and not statistically significant. However, such small changes in BMI may have 
positive implications, as Celli et al. (2004) have shown that even small change in BMI 
can provide a survival advantage to COPD patients. Such minimal alterations in BMI 
suggest that although it may be important for predicting mortality, it is not an effective 
predictor of patient readmission into pulmonary rehabilitation.  
 The LOS was also found to have little predictive strength regarding the return of 
patients to pulmonary rehabilitation. There were no significant differences between the 
NR and R groups, as the mean LOS was 155 days for each group. Green, Singh, 
Williams, and Morgan (2001) compared a 4-week pulmonary rehabilitation program to 
a 7-week program and found that the 7-week program resulted in enhanced patient 




Green et al. (2001) suggests that the longer the LOS for patients involved in a 
pulmonary rehabilitation program the greater the benefits for the patients. The current 
study showed a similar LOS for both groups, suggesting that although the LOS might  
be a logical predictor of readmission into pulmonary rehabilitation, the data collected 
for the purpose of this study do not support such a notion.  
L imitat ions 
 The limitations of this study involved the literature reviewed, study location, and 
data collection. The existing available literature comparing readmission and pulmonary 
rehabilitation was limited to only readmission into a hospital bed setting (e.g., 
emergency room or over-night stay) and not back into a pulmonary rehabilitation 
program. There are also a limited number of studies specifically examining the 
relationship between BMI and pulmonary rehabilitation. The sample used in this study 
was very limited regarding demographic background, due to the geographical location 
of data collection. For example, our homogenous sample consisted of a vast majority 
(98%) of Caucasian patients over the age of 60, so this data may not be able to be 
generalized to the greater population. The method used to document records of 
pulmonary rehabilitation was changed after 2005 in the Altru hospital database. This 
change in systems limited the available pool of data used for this study due to the 
inability to access the older records. Along with the database change for pulmonary 
rehabilitation, not all medical records were available in the same system as the 
pulmonary rehabilitation records, which limited the information collected including the 




transferred to another hospital or died. For these reasons a patient was not included in  
this study if they did not fully complete pulmonary rehabilitation at Altru Health 
System’s pulmonary rehabilitation unit. 
 Future researchers should consider whether or not pulmonary rehabilitation 
patients may have transferred to another facility or passed away prior to readmission 
into rehabilitation, because the records from the other facilities or death records may 
not have been submitted to the original hospital to update the patient’s medical records. 
Greater focus on the main causes to the readmission of a patient into pulmonary 
rehabilitation, such as disease, exacerbations, or lifestyle changes, might be more 
predictive than pulmonary function data taken at the start and end of the program. More 
studies should also be conducted to test whether drug treatments, including inhaled 
corticosteroids and broncholdilators, increase the lung function tests from pre- to post-
rehabilitation and correlate with the walking tests. These lung function tests, while on 
medication, may create better predictors for readmission into a pulmonary 
rehabilitation program. 
Conclusion 
 The current study attempted to determine the likelihood for readmission into a 
pulmonary rehabilitation program by asking the following questions: which variable 
was the best predictor for readmission into a pulmonary rehabilitation program, how 
well did each variable predict, and which assessment test, 6MWT or PEFR, was better 
at predicting readmission?  The findings for the primary question revealed that out of 




was the strongest predictor. However, in answering our second question, it was clear 
that the predictors examined were not particularly good at predicting readmission into a 
pulmonary rehabilitation program. Finally, the answer to the third question was that the 
6MWT was a better predictor than PEFR. 
 Considering the fact that most patients (74%) were never readmitted, and that 
the majority of 6MWT were increased by 226 ft. (69 m), pulmonary rehabilitation 
appears to still be an effective tool in managing COPD.  The results provided showed 
that there was not one specific predictor that strongly indicated the likelihood for 
readmission, suggesting there are perhaps a plethora of variables outside of those linked 
specifically to pulmonary rehabilitation may be influencing a patient with COPD. 
However, the findings from this study seem to suggest that the further the start and end 
6MWT was below the normal values, the more likely it was that a patient would be 
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